These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
143 related articles for article (PubMed ID: 20684850)
21. Immunogenicity of Mycobacterium tuberculosis antigens in Mycobacterium bovis BCG-vaccinated and M. bovis-infected cattle. Mustafa AS; Skeiky YA; Al-Attiyah R; Alderson MR; Hewinson RG; Vordermeier HM Infect Immun; 2006 Aug; 74(8):4566-72. PubMed ID: 16861643 [TBL] [Abstract][Full Text] [Related]
22. Bovine TB and the development of new vaccines. Hope JC; Villarreal-Ramos B Comp Immunol Microbiol Infect Dis; 2008 Mar; 31(2-3):77-100. PubMed ID: 17764740 [TBL] [Abstract][Full Text] [Related]
23. Toward the development of diagnostic assays to discriminate between Mycobacterium bovis infection and bacille Calmette-Guérin vaccination in cattle. Vordermeier HM; Cockle PJ; Whelan AO; Rhodes S; Hewinson RG Clin Infect Dis; 2000 Jun; 30 Suppl 3():S291-8. PubMed ID: 10875803 [TBL] [Abstract][Full Text] [Related]
24. Vaccination with Mycobacterium bovis BCG strains Danish and Pasteur in white-tailed deer (Odocoileus virginianus) experimentally challenged with Mycobacterium bovis. Palmer MV; Thacker TC; Waters WR Zoonoses Public Health; 2009 Jun; 56(5):243-51. PubMed ID: 19175569 [TBL] [Abstract][Full Text] [Related]
25. First data on Eurasian wild boar response to oral immunization with BCG and challenge with a Mycobacterium bovis field strain. Ballesteros C; Garrido JM; Vicente J; Romero B; Galindo RC; Minguijón E; Villar M; Martín-Hernando MP; Sevilla I; Juste R; Aranaz A; de la Fuente J; Gortázar C Vaccine; 2009 Nov; 27(48):6662-8. PubMed ID: 19747578 [TBL] [Abstract][Full Text] [Related]
26. Comparison of the protective efficacy of bacille calmette-Guérin vaccination against aerosol challenge with Mycobacterium tuberculosis and Mycobacterium bovis. Williams A; Davies A; Marsh PD; Chambers MA; Hewinson RG Clin Infect Dis; 2000 Jun; 30 Suppl 3():S299-301. PubMed ID: 10875804 [TBL] [Abstract][Full Text] [Related]
27. The safety and immunogenicity of Bacillus Calmette-Guérin (BCG) vaccine in European badgers (Meles meles). Lesellier S; Palmer S; Dalley DJ; Davé D; Johnson L; Hewinson RG; Chambers MA Vet Immunol Immunopathol; 2006 Jul; 112(1-2):24-37. PubMed ID: 16687176 [TBL] [Abstract][Full Text] [Related]
28. Identification of immune response correlates for protection against bovine tuberculosis. Buddle BM; Wedlock DN; Denis M; Skinner MA Vet Immunol Immunopathol; 2005 Oct; 108(1-2):45-51. PubMed ID: 16140388 [TBL] [Abstract][Full Text] [Related]
29. Evaluation of BCG vaccine and Mycobacterium bovis culture filtrate proteins against bovine tuberculosis. Díaz-Otero F; Padilla J; Jaramillo L; González D; Arriaga C Ann N Y Acad Sci; 2008 Dec; 1149():306-8. PubMed ID: 19120235 [TBL] [Abstract][Full Text] [Related]
30. Influence of sensitisation to environmental mycobacteria on subsequent vaccination against bovine tuberculosis. Buddle BM; Wards BJ; Aldwell FE; Collins DM; de Lisle GW Vaccine; 2002 Jan; 20(7-8):1126-33. PubMed ID: 11803073 [TBL] [Abstract][Full Text] [Related]
31. Partial protection against oral challenge with Mycobacterium bovis in ferrets (Mustela furo) following oral vaccination with BCG. Qureshi T; Labes RE; Cross ML; Griffin JF; Mackintosh CG Int J Tuberc Lung Dis; 1999 Nov; 3(11):1025-33. PubMed ID: 10587325 [TBL] [Abstract][Full Text] [Related]
32. Adverse reactions to Mycobacterium bovis bacille Calmette-Guérin (BCG) vaccination against tuberculosis in humans, veterinary animals and wildlife species. Murphy D; Corner LA; Gormley E Tuberculosis (Edinb); 2008 Jul; 88(4):344-57. PubMed ID: 18222731 [TBL] [Abstract][Full Text] [Related]
33. Development of a Mycobacterium bovis intranasal challenge model in mice. Logan KE; Gavier-Widen D; Hewinson RG; Hogarth PJ Tuberculosis (Edinb); 2008 Sep; 88(5):437-43. PubMed ID: 18590980 [TBL] [Abstract][Full Text] [Related]
34. Exposure to Mycobacterium avium can modulate established immunity against Mycobacterium tuberculosis infection generated by Mycobacterium bovis BCG vaccination. Flaherty DK; Vesosky B; Beamer GL; Stromberg P; Turner J J Leukoc Biol; 2006 Dec; 80(6):1262-71. PubMed ID: 16968819 [TBL] [Abstract][Full Text] [Related]
35. Immune response to postprimary tuberculosis in mice: Mycobacterium tuberculosis and Miycobacterium bovis bacille Calmette-Guérin induce equal protection. Mollenkopf HJ; Kursar M; Kaufmann SH J Infect Dis; 2004 Aug; 190(3):588-97. PubMed ID: 15243936 [TBL] [Abstract][Full Text] [Related]
36. Efficacy of oral BCG vaccination in protecting free-ranging cattle from natural infection by Mycobacterium bovis. Nugent G; Yockney IJ; Whitford J; Aldwell FE; Buddle BM Vet Microbiol; 2017 Sep; 208():181-189. PubMed ID: 28888636 [TBL] [Abstract][Full Text] [Related]
37. Factors influencing the protective efficacy of a BCG homologous prime-boost vaccination regime against tuberculosis. Griffin JF; Mackintosh CG; Rodgers CR Vaccine; 2006 Feb; 24(6):835-45. PubMed ID: 16098638 [TBL] [Abstract][Full Text] [Related]
38. Development of a simple, sensitive, rapid test which discriminates BCG-vaccinated from Mycobacterium bovis-infected cattle. Sopp P; Coad M; Hewinson G; Howard CJ; Cheallaigh CN; Keane J; Harris J; Hope JC Vaccine; 2008 Oct; 26(43):5470-6. PubMed ID: 18692540 [TBL] [Abstract][Full Text] [Related]